Driehaus Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Sell |
|
|||||
|
2025
Q1 | $154M | Buy |
|
|||||
|
2024
Q4 | $177M | Sell |
|
|||||
|
2024
Q3 | $181M | Buy |
|
|||||
|
2024
Q2 | $172M | Buy |
|
|||||
|
2024
Q1 | $186M | Sell |
|
|||||
|
2023
Q4 | $200M | Sell |
|
|||||
|
2023
Q3 | $154M | Sell |
|
|||||
|
2023
Q2 | $183M | Buy |
|
|||||
|
2023
Q1 | $167M | Sell |
|
|||||
|
2022
Q4 | $185M | Buy |
|
|||||
|
2022
Q3 | $163M | Buy |
|
|||||
|
2022
Q2 | $134M | Buy |
|
|||||
|
2022
Q1 | $101M | Buy |
|
|||||
|
2021
Q4 | $97.6M | Buy |
|
|||||
|
2021
Q3 | $23.1M | Buy |
|
|||||
|
2021
Q2 | $17.6M | Buy |
|
|||||
|
2021
Q1 | $13.8M | Buy |
|
|||||
|
2020
Q4 | $6.85M | Sell |
|
|||||
|
2020
Q3 | $5M | Sell |
|
|||||
|
2020
Q2 | $5.82M | Buy |
|
|||||
|
2020
Q1 | $5.24M | Buy |
|